06 August 2024 : Original article
Abnormal Liver Biopsies of Donor Grafts in Pediatric Liver Transplantation: How Do They Fare?
Jason GuoDOI: 10.12659/AOT.944245
Ann Transplant 2024; 29:e944245
Table 3 Outcomes of recipients of biopsied normal and abnormal livers.
| Outcome characteristics | Biopsied normal liver (N=114) | Abnormal liver (N=99) | p-value* |
|---|---|---|---|
| Length of stay (d)*** | 17 (11, 28.5) | 18 (12, 32) | 0.7 |
| Rejection episode during admission** | 15 (13%) | 9 (9.1%) | 0.3 |
| Treated for rejection within 6mo** | 20 (18%) | 11 (11%) | 0.2 |
| Treated for rejection within 1yr** | 21 (18%) | 16 (16%) | 0.7 |
| 1-year graft survival** | 109 (96%) | 93 (94%) | 0.6 |
| Graft failure cause** | |||
| Primary non-function | 1 (0.9%) | 2 (2.0%) | 0.6 |
| Recurrent disease | 0 (0.0%) | 1 (1.0%) | 0.5 |
| Hepatic artery thrombosis | 2 (1.8%) | 1 (1.0%) | >0.9 |
| Portal vein thrombosis | 2 (1.8%) | 0 (0.0%) | 0.5 |
| Other vascular thrombosis | 2 (1.8%) | 0 (0.0%) | 0.5 |
| Rejection chronic | 1 (0.9%) | 0 (0.0%) | >0.9 |
| * Wilcoxon rank sum test; Fisher’s exact test; Pearson’s Chi-squared test; ** n (%); *** median (IQR). | |||






